94748 ⎘
Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Sub-classes:Methods of Making Deuterium-Enriched N-Acetylcysteine Amide (D-NACA) and (2R,2R)-3,3-Disulfanediyl BIS(2-Acetamidopropanamide) (DINACA) and Using D-NACA and DINACA to Treat Diseases Involving Oxidative Stress
#2Methods of Making Deuterium-Enriched N-Acetylcysteine Amide (D-NACA) and (2R,2R)-3,3-Disulfanediyl BIS(2-Acetamidopropanamide) (DINACA) and Using D-NACA and DINACA to Treat Diseases Involving Oxidative Stress
#3Methods of making deuterium-enriched N-acetylcysteine amide (d-NACA) and (2R, 2R′)-3,3′-disulfanediyl bis(2-acetamidopropanamide) (diNACA) and using d-NACA and diNACA to treat diseases involving oxidative stress
#4Methods of Making Deuterium-Enriched N-acetylcysteine Amide (D-NACA) and (2R, 2R')-3,3'-Disulfanediyl BIS(2-Acetamidopropanamide) (DINACA) and Using D-NACA and DINACA to Treat Diseases Involving Oxidative Stress
#5DESFERRITHIOCIN POLYETHER ANALOGUES
#6Metabolically programmed metal chelators and uses thereof
#7IRE-1alpha INHIBITORS
#8Desferrithiocin polyether analogues
#9IRE-1alpha inhibitors
#10Desferrithiocin analogs and uses thereof
#11Polymorph forms of desazadesferrithiocin analogs
#12Desferrithiocin polyether analogues
#13Desferrithiocin polyether analogues
#14POLYMORPH FORMS OF DESAZADESFERRITHIOCIN ANALOGS
#15USES OF 3'-DESFERRITHIOCIN ANALOGS
#16Desferrithiocin polyether analogues
#17Luminescent substrate for luciferase
#18Methods and compositions related to neuroactive thiazoline compounds
#19Oral formulations for treating metal overload
#20Desferrithiocin polyether analogues
#21DESAZADESFERROTHIOCIN AND DESAZADESFERROTHIOCIN POLYETHER ANALOGUES AS METAL CHELATION AGENTS
#22Desferrithiocin polyether analogues
#23Convenient Synthesis of Azolines to Azoles
#24PRODRUGS OF DESAZADESFERROTHIOCIN POLYETHER ANALOGUES AS METAL CHELATION AGENTS
#25Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents
#26IRE-1α inhibitors
#27Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents
#28DESFERRITHIOCIN POLYETHER ANALOGUES AND USES THEREOF
#29Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents
#30Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents
#31PRODRUGS OF DESAZADESFERROTHIOCIN POLYETHER ANALOGUES AS METAL CHELATION AGENTS
#32Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents
#33Thiazoline acid derivatives
#34Desferrithiocin polyether analogues
#35N-hydroxyamide derivatives possessing antibacterial activity
#36TYROSINE DERIVATIVE
#37Indanyl- and tetrahydronaphtyl-amino-thiourea compounds for combating animal pests
#38THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, AND SERINE AMIDES, INCLUDING POLYAMINE CONJUGATES THEREOF, AS SELECTIVE ANTI-CANCER AGENTS
#39Desferrithiocin polyether analogues
#40Thiazoline acid derivatives
#41Iron binding agents
#42Novel compounds useful for bradykinin B1 receptor antagonism
#43Synthesis of 2-alkylcysteine via phase transfer catalysis
#44Production methods of thiazoline compounds and optically active alpha-alkylcysteine
#45Synthesis of substituted thiazoline carboxylic acids
#46Desferrithiocin derivatives and methods of use thereof
#47Synthesis of 2-alkyl amino acids
#48Synthesis of 2-alkyl amino acids
#49Synthesis of chiral 2-alkyl amino acids
#50Process for producing optically active alpha-substituted cysteine or salt thereof, intermediate therefor, and process for producing the same
#51Pyrrolidine and thiazolidine compounds
#52Iron binding agents
#53Synthesis of a 4-methylthiazole-4(S)-carboxylic acid compound
#54Process for the preparation of substituted thiazolines and their intermediates
#55Methods and compositions for the treatment of amyloid-and epileptogenesis-associated diseases
#56Thiazoline acid derivatives
#57Novel thiazoline derivatives as selective androgen receptor modulators (SARMS)